Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy

Purpose Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimate...

Full description

Saved in:
Bibliographic Details
Published inInternational urology and nephrology Vol. 50; no. 4; pp. 715 - 723
Main Authors Wang, Tao, Zhang, Yan, Wang, Ning, Liu, Qiong, Wang, ZeKai, Liu, Bing, Niu, Kai
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.04.2018
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0301-1623
1573-2584
1573-2584
DOI10.1007/s11255-018-1812-2

Cover

Abstract Purpose Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease. Methods A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography–tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated. Results The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene–gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes. Conclusions By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.
AbstractList Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.PURPOSESince altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.METHODSA total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.RESULTSThe Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.CONCLUSIONSBy uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.
PurposeSince altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.MethodsA total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography–tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.ResultsThe Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene–gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.ConclusionsBy uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.
Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease. A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated. The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes. By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.
Purpose Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease. Methods A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography–tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated. Results The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene–gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes. Conclusions By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.
Author Liu, Bing
Wang, Ning
Liu, Qiong
Niu, Kai
Wang, Tao
Zhang, Yan
Wang, ZeKai
Author_xml – sequence: 1
  givenname: Tao
  orcidid: 0000-0002-7370-7299
  surname: Wang
  fullname: Wang, Tao
  email: nephrology2009@hotmail.com
  organization: Department of Nephrology, HeBei General Hospital
– sequence: 2
  givenname: Yan
  surname: Zhang
  fullname: Zhang, Yan
  organization: Department of Dermatology, The 4th Affiliated Hospital of HeBei Medical University
– sequence: 3
  givenname: Ning
  surname: Wang
  fullname: Wang, Ning
  organization: Department of Radiology, The 4th Affiliated Hospital of HeBei Medical University
– sequence: 4
  givenname: Qiong
  surname: Liu
  fullname: Liu, Qiong
  organization: Department of Nephrology, HeBei General Hospital
– sequence: 5
  givenname: ZeKai
  surname: Wang
  fullname: Wang, ZeKai
  organization: Department of Nephrology, HeBei General Hospital
– sequence: 6
  givenname: Bing
  surname: Liu
  fullname: Liu, Bing
  organization: Department of Nephrology, HeBei General Hospital
– sequence: 7
  givenname: Kai
  surname: Niu
  fullname: Niu, Kai
  organization: Department of Nephrology, HeBei General Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29404926$$D View this record in MEDLINE/PubMed
BookMark eNp9kcGK1TAYhYOMOHdGH8CNBNy4qSZp0zRLuegoDLhQ1yE3_XubIU1qkiJ9LZc-hM806dwZkAFd_SR85-TkPxfozAcPCL2k5C0lRLxLlDLOK0K7inaUVewJ2lEu6orxrjlDO1ITWtGW1efoIqUbQojsCHmGzplsSCNZu0O_v64e4tGmbI12WJtsg8dhwHkE_OcXw7qP4IOBOYeIte_xoHNeC2h7fLC-t_6I5xgyWI8ZnoNbpxDn0aYp4eK02biQ0mZ5dGGCuDgd8WBdjvrurTIAF_F-tB4S4Llcg88J_7R5xHmdofj2Vh-gRMQe5jGGwozrc_R00C7Bi_t5ib5__PBt_6m6_nL1ef_-ujKsE6wSXHdtAxRkaxrREqlB6g6IaQ0YZvoWysmITgyN0BwolbpnpgUpqODDoa8v0ZuTb_nmjwVSVpNNBpzTHsKSFJWSU85ZVxf09SP0JizRl3Qb1TAimWgL9eqeWg4T9GqOdtJxVQ-tFECcABPL6iIMyth8t62yNOsUJWrrX536V6V_tfWvWFHSR8oH8_9p2EmTCuuPEP8K_U_RLXfcxiA
CitedBy_id crossref_primary_10_3389_fmed_2024_1444719
crossref_primary_10_1111_nep_13544
crossref_primary_10_3389_fgene_2019_00507
crossref_primary_10_1155_2022_5700249
Cites_doi 10.1016/j.semnephrol.2012.07.003
10.2174/157339910790909396
10.1291/hypres.31.561
10.2337/diabetes.54.11.3326
10.1152/physiolgenomics.00070.2001
10.1007/s11906-003-0084-z
10.1016/0735-1097(88)90382-8
10.1152/physrev.00001.2010
10.1111/j.1440-1681.2008.04990.x
10.1161/01.HYP.0000121881.77212.b1
10.1017/S002966510800596X
10.1007/978-3-540-79088-4_11
10.1016/S0895-7061(01)02236-1
10.2165/00003495-200767070-00005
10.1111/j.1476-5381.2009.00187.x
10.1086/321276
10.1161/01.HYP.0000091371.53502.D3
10.1681/ASN.2006040368
10.1046/j.1523-1755.63.s84.24.x
10.5152/dir.2014.13513
10.1111/j.1476-5381.1985.tb11094.x
10.1038/ajh.2009.70
10.1291/hypres.30.503
10.1177/147323000603400308
10.2147/DMSO.S45183
10.1159/000313927
10.1038/nrneph.2010.152
10.2215/CJN.02560607
10.1111/1440-1681.12268
10.3892/ijmm_00000161
ContentType Journal Article
Copyright Springer Science+Business Media B.V., part of Springer Nature 2018
International Urology and Nephrology is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Springer Science+Business Media B.V., part of Springer Nature 2018
– notice: International Urology and Nephrology is a copyright of Springer, (2018). All Rights Reserved.
DBID AAYXX
CITATION
NPM
3V.
7QP
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s11255-018-1812-2
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Academic Middle East (New)
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2584
EndPage 723
ExternalDocumentID 29404926
10_1007_s11255_018_1812_2
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
NPM
7QP
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c2872-75a864e1e96c47609ae9a8e0c6cec2cd6ea8ec787f47a5e119ad2c6e97175fbd3
IEDL.DBID U2A
ISSN 0301-1623
1573-2584
IngestDate Thu Sep 04 16:36:59 EDT 2025
Sat Aug 16 06:21:02 EDT 2025
Mon Jul 21 05:49:51 EDT 2025
Tue Jul 01 01:24:07 EDT 2025
Thu Apr 24 23:04:52 EDT 2025
Fri Feb 21 02:35:44 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Type 2 diabetes
Diabetic nephropathy
β2-Adrenergic receptor
Single nucleotide polymorphism
Fatty acid binding protein-2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2872-75a864e1e96c47609ae9a8e0c6cec2cd6ea8ec787f47a5e119ad2c6e97175fbd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7370-7299
PMID 29404926
PQID 1994209276
PQPubID 33540
PageCount 9
ParticipantIDs proquest_miscellaneous_1995155283
proquest_journals_1994209276
pubmed_primary_29404926
crossref_citationtrail_10_1007_s11255_018_1812_2
crossref_primary_10_1007_s11255_018_1812_2
springer_journals_10_1007_s11255_018_1812_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180400
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 4
  year: 2018
  text: 20180400
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationTitle International urology and nephrology
PublicationTitleAbbrev Int Urol Nephrol
PublicationTitleAlternate Int Urol Nephrol
PublicationYear 2018
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Najafian, Mauer (CR32) 2012; 32
Weiss, Brown, Shuldiner, Hagberg (CR12) 2002; 10
Cakmak, Yağcı, Dursun, Herek, Fenkçi (CR19) 2014; 20
Masuo, Katsuya, Sugimoto, Kawaguchi, Rakugi, Ogihara, Tuck (CR11) 2007; 30
Kudat, Akkaya, Sozen, Salman, Demirel, Ozcan, Atilgan, Yilmaz, Guven (CR18) 2006; 34
Van Eenoo, Delbeke (CR21) 2010; 195
Wang, Zhang, Ma, Feng, Niu, Liu (CR20) 2014; 41
Esler, Rumantir, Wisener, Kaye, Lambert, Hasting (CR5) 2001; 14
Yoshida, Kato, Yokoi, Watanabe, Metoki, Yoshida, Satoh, Aoyagi, Nishigaki, Suzuki, Nozawa, Yamada (CR13) 2009; 23
Canani, Capp, Ng, Choo, Maia, Nabinger, Santos, Crispim, Roisemberg, Krolewski, Gross (CR9) 2005; 54
Nashar, Egan (CR26) 2014; 7
Dorn (CR24) 2010; 90
Atala, Goulart, Guerra, Mostarda, Rodrigues, Mello, Casarine, Irigoyen, Pereira, Consolim-Colombo (CR25) 2015; 7
Nakagawa, Tanabe, Croker, Johnson, Grant, Kosugi, Li (CR1) 2011; 7
Hall, Jones, Kuo, da Silva, Tallam, Liu (CR4) 2003; 5
Leineweber, Heusch (CR10) 2009; 58
Francis (CR23) 1988; 12
Masuo, Kawaguchi, Mikami, Ogihara, Tuck (CR16) 2003; 42
Göthert, Hentrich (CR22) 1985; 85
Chen, Lipkowitz, Salem, Fung, Bhatnagar, Mahata, Nievergelt, Rao, Mahata, Schork, Hicks, Bowden, Freedman, Brophy, O’Connor (CR8) 2010; 32
Wang, Karino, Yamasaki, Zhang, Masuda, Yamaguchi, Shiwaku, Nabika (CR15) 2009; 22
Ritchie, Hahn, Roodi, Bailey, Dupont, Parl, Moore (CR28) 2001; 69
Wang, Nabika, Notsu, Takabatake (CR30) 2008; 31
Marti, Martinez-González, Martinez (CR14) 2008; 67
Wang, Takabatake, Kobayashi, Nabika (CR31) 2008; 35
Lindner, Wanner, Berger (CR6) 2003; 63
Ma, Zuo, Chen, Luo, Yu, Li, Xu, Huang, Wang, Huang, Wang, Xu, Wang (CR17) 2006; 17
Masuo, Rakugi, Ogihara, Esler, Lambert (CR27) 2010; 6
Coccheri (CR2) 2007; 67
Joles, Koomans (CR3) 2004; 43
Sinski, Lewandowski, Abramczyk, Narkiewicz, Gaciong (CR29) 2006; 57
Freedman, Bostrom, Daeihagh, Bowden (CR7) 2007; 2
T Wang (1812_CR20) 2014; 41
T Yoshida (1812_CR13) 2009; 23
S Coccheri (1812_CR2) 2007; 67
D Lindner (1812_CR6) 2003; 63
LH Canani (1812_CR9) 2005; 54
T Wang (1812_CR15) 2009; 22
K Nashar (1812_CR26) 2014; 7
P Cakmak (1812_CR19) 2014; 20
T Nakagawa (1812_CR1) 2011; 7
B Najafian (1812_CR32) 2012; 32
YC Ma (1812_CR17) 2006; 17
MM Atala (1812_CR25) 2015; 7
K Masuo (1812_CR27) 2010; 6
K Masuo (1812_CR11) 2007; 30
H Kudat (1812_CR18) 2006; 34
Y Chen (1812_CR8) 2010; 32
M Göthert (1812_CR22) 1985; 85
T Wang (1812_CR30) 2008; 31
EP Weiss (1812_CR12) 2002; 10
M Esler (1812_CR5) 2001; 14
K Leineweber (1812_CR10) 2009; 58
T Wang (1812_CR31) 2008; 35
JA Joles (1812_CR3) 2004; 43
JE Hall (1812_CR4) 2003; 5
K Masuo (1812_CR16) 2003; 42
MD Ritchie (1812_CR28) 2001; 69
GS Francis (1812_CR23) 1988; 12
BI Freedman (1812_CR7) 2007; 2
P Eenoo Van (1812_CR21) 2010; 195
M Sinski (1812_CR29) 2006; 57
GW Dorn 2nd (1812_CR24) 2010; 90
A Marti (1812_CR14) 2008; 67
References_xml – volume: 32
  start-page: 415
  issue: 5
  year: 2012
  end-page: 422
  ident: CR32
  article-title: Morphological features of declining renal function in type 1 diabetes
  publication-title: Semin Nephrol
  doi: 10.1016/j.semnephrol.2012.07.003
– volume: 6
  start-page: 58
  issue: 2
  year: 2010
  end-page: 67
  ident: CR27
  article-title: Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance
  publication-title: Curr Diabetes Rev
  doi: 10.2174/157339910790909396
– volume: 31
  start-page: 561
  issue: 3
  year: 2008
  end-page: 568
  ident: CR30
  article-title: Sympathetic regulation of renal functions in the SHRSP-based congenic rats for chromosome-1 blood pressure QTL
  publication-title: Hypertens Res
  doi: 10.1291/hypres.31.561
– volume: 54
  start-page: 3326
  issue: 11
  year: 2005
  end-page: 3330
  ident: CR9
  article-title: The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.11.3326
– volume: 10
  start-page: 145
  issue: 3
  year: 2002
  end-page: 157
  ident: CR12
  article-title: Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00070.2001
– volume: 5
  start-page: 386
  issue: 5
  year: 2003
  end-page: 392
  ident: CR4
  article-title: Impact of the obesity epidemic on hypertension and renal disease
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-003-0084-z
– volume: 12
  start-page: 250
  issue: 1
  year: 1988
  end-page: 254
  ident: CR23
  article-title: Modulation of peripheral sympathetic nerve transmission
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(88)90382-8
– volume: 90
  start-page: 1013
  issue: 3
  year: 2010
  end-page: 1062
  ident: CR24
  article-title: Adrenergic signaling polymorphisms and their impact on cardiovascular disease
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00001.2010
– volume: 35
  start-page: 1365
  issue: 11
  year: 2008
  end-page: 1370
  ident: CR31
  article-title: Sympathetic regulation of the renal functions in the reciprocal congenic rats for chromosome 1 blood pressure QTL
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1111/j.1440-1681.2008.04990.x
– volume: 43
  start-page: 699
  issue: 4
  year: 2004
  end-page: 706
  ident: CR3
  article-title: Causes and consequences of increased sympathetic activity in renal disease
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000121881.77212.b1
– volume: 67
  start-page: 1
  issue: 1
  year: 2008
  end-page: 8
  ident: CR14
  article-title: Interaction between genes and lifestyle factors on obesity
  publication-title: Proc Nutr Soc
  doi: 10.1017/S002966510800596X
– volume: 195
  start-page: 227
  year: 2010
  end-page: 249
  ident: CR21
  article-title: Beta-adrenergic stimulation
  publication-title: Handb Exp Pharmacol
  doi: 10.1007/978-3-540-79088-4_11
– volume: 14
  start-page: 304S
  issue: 11–2
  year: 2001
  end-page: 309S
  ident: CR5
  article-title: Sympathetic nervous system and insulin resistance from obesity to diabetes
  publication-title: Am J Hyperten
  doi: 10.1016/S0895-7061(01)02236-1
– volume: 7
  start-page: 153
  issue: 1
  year: 2015
  end-page: 161
  ident: CR25
  article-title: Arg16Gly and Gln27Glu β2 adrenergic polymorphisms influence cardiac autonomic modulation and baroreflex sensitivity in healthy young Brazilians
  publication-title: Am J Transl Res
– volume: 67
  start-page: 997
  issue: 7
  year: 2007
  end-page: 1026
  ident: CR2
  article-title: Approaches to prevention of cardiovascular complications and events in diabetes mellitus
  publication-title: Drugs
  doi: 10.2165/00003495-200767070-00005
– volume: 58
  start-page: 61
  issue: 1
  year: 2009
  end-page: 69
  ident: CR10
  article-title: β1- and β2-adrenoceptor polymorphisms and cardiovascular diseases
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.2009.00187.x
– volume: 69
  start-page: 138
  issue: 1
  year: 2001
  end-page: 147
  ident: CR28
  article-title: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer
  publication-title: Am J Hum Genet
  doi: 10.1086/321276
– volume: 42
  start-page: 474
  issue: 4
  year: 2003
  end-page: 480
  ident: CR16
  article-title: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000091371.53502.D3
– volume: 57
  start-page: 79
  issue: Suppl 11
  year: 2006
  end-page: 92
  ident: CR29
  article-title: Why study sympathetic nervous system?
  publication-title: J Physiol Pharmacol
– volume: 17
  start-page: 2927
  year: 2006
  end-page: 2944
  ident: CR17
  article-title: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006040368
– volume: 63
  start-page: S186
  issue: 84
  year: 2003
  end-page: S1913
  ident: CR6
  article-title: Genetic aspects of diabetic nephropathy
  publication-title: Kidney Int Suppl
  doi: 10.1046/j.1523-1755.63.s84.24.x
– volume: 20
  start-page: 374
  issue: 5
  year: 2014
  end-page: 378
  ident: CR19
  article-title: Renal diffusion-weighted imaging in diabetic nephropathy: correlation with clinical stages of disease
  publication-title: Diagn Interv Radiol
  doi: 10.5152/dir.2014.13513
– volume: 85
  start-page: 933
  issue: 4
  year: 1985
  end-page: 941
  ident: CR22
  article-title: Identification of presynaptic beta 2-adrenoceptors on the sympathetic nerve fibres of the human pulmonary artery
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1985.tb11094.x
– volume: 22
  start-page: 742
  issue: 7
  year: 2009
  end-page: 747
  ident: CR15
  article-title: Effects of G994T in the Lp-PLA gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese—the Shimane Study
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2009.70
– volume: 30
  start-page: 503
  issue: 6
  year: 2007
  end-page: 511
  ident: CR11
  article-title: High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.503
– volume: 23
  start-page: 529
  issue: 4
  year: 2009
  end-page: 537
  ident: CR13
  article-title: Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus
  publication-title: Int J Mol Med
– volume: 34
  start-page: 291
  issue: 3
  year: 2006
  end-page: 296
  ident: CR18
  article-title: Heart rate variability in diabetes patients
  publication-title: J Int Med Res
  doi: 10.1177/147323000603400308
– volume: 41
  start-page: 657
  issue: 9
  year: 2014
  end-page: 662
  ident: CR20
  article-title: Additive effect of polymorphisms in the β2-adrenoceptor and NADPH oxidase p22phox genes contributes to the loss of estimated glomerular filtration rate in Chinese
  publication-title: Clin Exp Pharmacol Physiol
– volume: 7
  start-page: 421
  year: 2014
  end-page: 435
  ident: CR26
  article-title: Relationship between chronic kidney disease and metabolic syndrome: current perspectives
  publication-title: Diabetes Metab Syndr Obes
  doi: 10.2147/DMSO.S45183
– volume: 32
  start-page: 23
  issue: 1
  year: 2010
  end-page: 30
  ident: CR8
  article-title: Progression of chronic kidney disease: adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis
  publication-title: Am J Nephrol
  doi: 10.1159/000313927
– volume: 7
  start-page: 36
  issue: 1
  year: 2011
  end-page: 44
  ident: CR1
  article-title: Endothelial dysfunction as a potential contributor in diabetic nephropathy
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2010.152
– volume: 2
  start-page: 1306
  issue: 6
  year: 2007
  end-page: 1316
  ident: CR7
  article-title: Genetic factors in diabetic nephropathy
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.02560607
– volume: 67
  start-page: 997
  issue: 7
  year: 2007
  ident: 1812_CR2
  publication-title: Drugs
  doi: 10.2165/00003495-200767070-00005
– volume: 17
  start-page: 2927
  year: 2006
  ident: 1812_CR17
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006040368
– volume: 5
  start-page: 386
  issue: 5
  year: 2003
  ident: 1812_CR4
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-003-0084-z
– volume: 14
  start-page: 304S
  issue: 11–2
  year: 2001
  ident: 1812_CR5
  publication-title: Am J Hyperten
  doi: 10.1016/S0895-7061(01)02236-1
– volume: 90
  start-page: 1013
  issue: 3
  year: 2010
  ident: 1812_CR24
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00001.2010
– volume: 42
  start-page: 474
  issue: 4
  year: 2003
  ident: 1812_CR16
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000091371.53502.D3
– volume: 20
  start-page: 374
  issue: 5
  year: 2014
  ident: 1812_CR19
  publication-title: Diagn Interv Radiol
  doi: 10.5152/dir.2014.13513
– volume: 63
  start-page: S186
  issue: 84
  year: 2003
  ident: 1812_CR6
  publication-title: Kidney Int Suppl
  doi: 10.1046/j.1523-1755.63.s84.24.x
– volume: 2
  start-page: 1306
  issue: 6
  year: 2007
  ident: 1812_CR7
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.02560607
– volume: 10
  start-page: 145
  issue: 3
  year: 2002
  ident: 1812_CR12
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00070.2001
– volume: 57
  start-page: 79
  issue: Suppl 11
  year: 2006
  ident: 1812_CR29
  publication-title: J Physiol Pharmacol
– volume: 58
  start-page: 61
  issue: 1
  year: 2009
  ident: 1812_CR10
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.2009.00187.x
– volume: 41
  start-page: 657
  issue: 9
  year: 2014
  ident: 1812_CR20
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1111/1440-1681.12268
– volume: 7
  start-page: 421
  year: 2014
  ident: 1812_CR26
  publication-title: Diabetes Metab Syndr Obes
  doi: 10.2147/DMSO.S45183
– volume: 195
  start-page: 227
  year: 2010
  ident: 1812_CR21
  publication-title: Handb Exp Pharmacol
  doi: 10.1007/978-3-540-79088-4_11
– volume: 7
  start-page: 36
  issue: 1
  year: 2011
  ident: 1812_CR1
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2010.152
– volume: 43
  start-page: 699
  issue: 4
  year: 2004
  ident: 1812_CR3
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000121881.77212.b1
– volume: 85
  start-page: 933
  issue: 4
  year: 1985
  ident: 1812_CR22
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1985.tb11094.x
– volume: 7
  start-page: 153
  issue: 1
  year: 2015
  ident: 1812_CR25
  publication-title: Am J Transl Res
– volume: 23
  start-page: 529
  issue: 4
  year: 2009
  ident: 1812_CR13
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm_00000161
– volume: 12
  start-page: 250
  issue: 1
  year: 1988
  ident: 1812_CR23
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(88)90382-8
– volume: 35
  start-page: 1365
  issue: 11
  year: 2008
  ident: 1812_CR31
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1111/j.1440-1681.2008.04990.x
– volume: 31
  start-page: 561
  issue: 3
  year: 2008
  ident: 1812_CR30
  publication-title: Hypertens Res
  doi: 10.1291/hypres.31.561
– volume: 69
  start-page: 138
  issue: 1
  year: 2001
  ident: 1812_CR28
  publication-title: Am J Hum Genet
  doi: 10.1086/321276
– volume: 6
  start-page: 58
  issue: 2
  year: 2010
  ident: 1812_CR27
  publication-title: Curr Diabetes Rev
  doi: 10.2174/157339910790909396
– volume: 30
  start-page: 503
  issue: 6
  year: 2007
  ident: 1812_CR11
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.503
– volume: 22
  start-page: 742
  issue: 7
  year: 2009
  ident: 1812_CR15
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2009.70
– volume: 32
  start-page: 23
  issue: 1
  year: 2010
  ident: 1812_CR8
  publication-title: Am J Nephrol
  doi: 10.1159/000313927
– volume: 67
  start-page: 1
  issue: 1
  year: 2008
  ident: 1812_CR14
  publication-title: Proc Nutr Soc
  doi: 10.1017/S002966510800596X
– volume: 54
  start-page: 3326
  issue: 11
  year: 2005
  ident: 1812_CR9
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.11.3326
– volume: 34
  start-page: 291
  issue: 3
  year: 2006
  ident: 1812_CR18
  publication-title: J Int Med Res
  doi: 10.1177/147323000603400308
– volume: 32
  start-page: 415
  issue: 5
  year: 2012
  ident: 1812_CR32
  publication-title: Semin Nephrol
  doi: 10.1016/j.semnephrol.2012.07.003
SSID ssj0009800
Score 2.1673837
Snippet Purpose Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the...
Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect...
PurposeSince altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 715
SubjectTerms Adrenergic receptors
Diabetes
Diabetes mellitus
Diabetic nephropathy
Diffusion coefficient
Epidermal growth factor receptors
Fatty acid-binding protein
Fatty acids
Gene polymorphism
Genetic analysis
Genotypes
Glomerular filtration rate
Heart rate
High-performance liquid chromatography
Homozygotes
Insulin
Insulin resistance
Magnetic resonance imaging
Mass spectroscopy
Medicine
Medicine & Public Health
Metabolic disorders
Nephrology
Nephrology - Original Paper
Nephropathy
Norepinephrine
Urology
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgLovwGChokTqCI4DjO5oSqiqpCKheotLfIa09QpGy83WwP-1oceQieiRnH2QVV7XEVZ9bSfPGM5-cbId6hmhUS8yJl8rJUkRFJmRIlRdSLyhYKteZu5PNv-uxCfZ0X8xhwG2JZ5XQmhoPaecsx8o_MYSuzSpb68-oy5alRnF2NIzTuinuBuozwXM7LPenubGxBIRDTXmQ-ZTVD6xxZdi5bozsU2bhU_m-Xrjmb1xKlwf6cPhIPo-MIx6OmD8Ud7B-L--cxNf5E_P6-5Ta-wLtM68Z-BfANkIcHf35JMNyz7bmKxa_B9A4as9lsaWHrYNGG5hYIrA1tDxJWvtsuPSmhHZYDkCQW09HOWeTPzi9xzQWs0LRdJN4FJp0AeplHcuOAEClbB-BYL3Csl-SOsd7WQo8rntBADuj2qbg4_fLj5CyNgxlSSxcs8sgLM9MKP2GlrSp1xgTfZoaZ1RattE4j_bJ0FDSqNAWSaoyTVmNFd8eiWbj8mTjofY8vBDR5QwDJbeOcU6ZQhpCipMGmklZZrBKRTWqpbWQt5-EZXb3nW2ZN1qTJmjVZy0S8372yGik7blt8NOm6jl_vUO-xloi3u8f03XEyxfTor8Iano5D3lkino8Y2f2brFTGRIyJ-DCB5h_hN23l5e1beSUeSIZrqBo6Egeb9RW-Jodos3gTUP8XJKIJww
  priority: 102
  providerName: ProQuest
Title Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy
URI https://link.springer.com/article/10.1007/s11255-018-1812-2
https://www.ncbi.nlm.nih.gov/pubmed/29404926
https://www.proquest.com/docview/1994209276
https://www.proquest.com/docview/1995155283
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9NAEF_0DsQX8b_Rs4zgkxJIN7ub5rFKz0O5Q9RCfQrbzewRSJPS9B76tXz0Q_iZnMmfVjkVfCqhk8mSmcnM7sz8RoiXqCZaYqxDBi8LFTmRkCFRQkSzTJ1WaAx3I59fmLO5er_Qi76Puxmq3YeUZPulPjS7kS_mQjPa9ZBXCum7e6xp687WOJfTA9LupOs7Ic2lBch4SGX-icXvzuhahHktO9o6ndO74k4fLcK0E-89cQOr--LWeZ8PfyC-f95x714Ltkx0XZMC1B4orIMf3yRYbtSuuXSl3oCtcvB2u90RYZHDsmg7WqCFaigqkLCuy92qpjdfNKsGiBOzKWnlzPKyrFe44apV8EXZo-0CI00A3cxzuLFB6HFaG-ADXuADXuLbHfAWDipc81gGijp3D8X8dPbl7VnYT2MIHe2qKAzXdmIUjjE1TiUmYlRvO8HIGYdOutwgXTmyf68Sq3E8Tm0uncGUNozaL_P4kTiq6gqfCPCxJ62Inc_zXFmtLKmHkhZ9Kp1ymAYiGsSSuR6qnCdmlNkBZJklmZEkM5ZkJgPxan_LusPp-BfxySDrrDfZJmOQZBmlMjGBeLH_m4yNMyi2wvqqpeGROBSSBeJxpyP7p8lURYy-GIjXg9L8wvxvS3n6X9TPxG3J2ttWDp2Io-3mCp9TULRdjsTNZJGMxPH03dcPM_p9M7v4-GnUmsZP5XsKPQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuiDeBAoMEF5CFs1lv4gNCPFqltIkQtFJvZrMeI0uOHeJUKH-KA0d-BL-JGT8SUEVvPVreHa81s7uzO_N9A_CU9DBQ1A88IS_zNG8inlCieERmGrpAkzGCRh5PzOhYfzgJTrbgR4uFkbTKdk2sFuq4cHJH_lI4bJUfqoF5Pf_mSdUoia62JTRqszig1Xc-spWv9t-zfp8ptbd79G7kNVUFPMenA3YnAzs0mnoUGqcHxhd2ajsk3xlHTrnYED85tuNED2xAvV5oY-UMhXzwCZJp3Ge5l2BbC6K1A9tvdycfP21ofoc16IWnDf-96rdx1Aqsx76EJMrxqY13VU_9uxOecW_PhGarHW_vOlxrXFV8U9vWDdii_CZcHjfB-Fvw6_NKgIMV0zO3qxESWCTIPiX-_qnQCkq8kLyZYoE2jzGxy-WKG6YxTtMKToMVT0Sao8J5ka1mBas9LWclsiQRk_HIReTXrJjRQlJmMUmzhuoXheYCubMUAaeSsCGJLVFul1Ful1lufbucOsxpLjUh2OVd3YbjC1HaHejkRU73AJN-wibZd0kcx9oG2rJtamUpCZXTjsIu-K1aItfwpEu5jizaMDyLJiPWZCSajFQXnq-7zGuSkPMa77S6jpr1oow21t2FJ-vXPNMlfGNzKk6rNlKPh_3BLtytbWT9NRVqX6gfu_CiNZq_hP9vKPfPH8pjuDI6Gh9Gh_uTgwdwVYnpVjlLO9BZLk7pIbtjy-mjZg4gfLnoafcHQbxJIg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkSouiH8CBQYJLqCoWcdxNgeEEGXVUlohQaW9Ba8zRpGyybLZCuW1OPYheCZm8rMLquitx2idibXzjT32zHwjxAtU40hiGPlMXuYr2kR8pkTxEfUssZFCrbka-fhEH5yqj9NouiXOh1oYTqsc1sR2oc4qy3fke8xhK4NExnrP9WkRn_cnbxc_fO4gxZHWoZ1GB5EjbH7S8a1-c7hPun4p5eTD1_cHft9hwLd0UiDXMjJjrXCEibYq1gEzVZsxBlZbtNJmGunJEqadik2Eo1FiMmk1JnQIitwsC0nuNXE9DsmrIluKp_GG8Hfclb-QAdH_IMMhotqW7ZFXwSlzdH6j_dWX_-6JFxzdC0Hadu-b3BI3e6cV3nUouy22sLwjdo77sPxdcf6l4RLClvOZxnW1ElA5IO8Sfv-SYLhevOIMmmoJpszAmdWqoYF5BrO8LayBljEiL0HCoiqaeUUAyOt5DSSJxRQ0cxb5vajmuOTkWXB50ZP-AhNeAL3M7cCxRujpYmvge2bge2aS290z5xZKXHB3CHJ-m3vi9EpUdl9sl1WJDwW40BE4Q-uyLFMmUoZQqqRBl0irLCaeCAa1pLZnTOfGHUW64XpmTaakyZQ1mUpPvFq_sujoQi4bvDvoOu1Xjjrd4NwTz9c_k81zIMeUWJ21Y7gzD3mGnnjQYWT9NZmogEkgPfF6AM1fwv83lUeXT-WZ2CFjSz8dnhw9FjckI7dNXtoV26vlGT4hv2w1e9oaAIhvV21xfwC56kvp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synergistical+action+of+the+%CE%B22+adrenoceptor+and+fatty+acid+binding+protein+2+polymorphisms+on+the+loss+of+glomerular+filtration+rate+in+Chinese+patients+with+type+2+diabetic+nephropathy&rft.jtitle=International+urology+and+nephrology&rft.au=Wang%2C+Tao&rft.au=Zhang%2C+Yan&rft.au=Wang%2C+Ning&rft.au=Liu%2C+Qiong&rft.date=2018-04-01&rft.eissn=1573-2584&rft_id=info:doi/10.1007%2Fs11255-018-1812-2&rft_id=info%3Apmid%2F29404926&rft.externalDocID=29404926
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-1623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-1623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-1623&client=summon